miRNA in situ hybridisation is a powerful technique that allows researchers to visualise and localise miRNAs within cells and tissues.
miRNA In Situ Hybridisation
Explore the Limitless Potential of IL-18
Researchers take advantage of MBL International’s recombinant IL-18 to activate varying cells like peripheral blood cells, macrophages, NK cells and T cells to identify targets.
The invaluable role of QuickSwitch™ kits in validating predicted results
Wang, Wenfeng, et al 2023, selected the top 15 top peptides for self-antigen for their study. By using the QuickSwitch™ kit, they successfully switched 6 peptides to the tetramer complex with an efficiency of over 75%.
Caspase Activity: Essential for Apoptosis
MBLI ‘s APOPCYTO Caspase-3,8,9 Colorimetric Assay Kit detects caspase activity in cell extract with LEHD-pNA as a substrate, in which LEHD sequence is recognised by each active caspase selectively.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
2D Differentiation of Epithelial Cells, Fibroblasts, and Melanocytes With Ease and Accuracy
CELLnTEC’s 2D differentiation media come in a fully supplemented, one-bottle ready-to-use formulation designed to create an environment conducive to cell differentiation.
Monoclonal vs. Polyclonal Antibodies
Leinco manufactures an extensive range of primary antibodies with the highest purity specifications available in the research products industry.
Immune Checkpoint Mechanism of Action
Leinco Technologies offers both GOLD™ and PLATINUM™ In vivo functional grade antibodies to important checkpoint markers for use in checkpoint research.
PhenoCycler-Fusion (CODEX)® Technology and Workflow Steps
PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.
Secondary Antibodies
Leinco Technologies offers a wide range of second step reagents including secondary antibodies, streptavidin and UltraAvidin™.